Quest Diagnostics, Inc.

NYSE:DGX   3:59:59 PM EDT
138.83
-3.47 (-2.44%)
Other Pre-Announcement

Quest Diagnostics Exec Says COVID-19 Testing Volumes Will Decline In 2022 Compared With 2021- JPM Conf

Published: 01/12/2022 16:13 GMT
Quest Diagnostics, Inc. (DGX) - Quest Diagnostics Exec Says Covid-19 Testing Volumes Will Decline in 2022 Compared With 2021- Jpm Conf.
Quest Diagnostics Exec Says Expect Covid-19 Testing to Be Significant Portion of 2022 Revenue, Believe Base Business is Now Fully Recovered- Jpm Conf.
Quest Diagnostics Exec Says Saw a Steep Increase in Covid-19 Testing Volumes in Q4, Particularly in the Last Two Weeks of December and Continuing Into January- Jpm Conf.
Quest Diagnostics Exec Says Expect Covid-19 Testing Opportunity to Continue Through Q1, But Decline As We Get Through Omicron Wave- Jpm Conf.
Quest Diagnostics Exec Says Performing North of 100,000 Covid-19 Tests per Day- Jpm Conf.